South Korea · Health Care · KRW (Millions) · Annual
Key financials
KRW|Millions
ROE
3.61%
2025 (actual)
ROA
2.77%
2025 (actual)
Gross Margin
57.94%
2025 (actual)
Net Margin
6.71%
2025 (actual)
Total Assets
₩581,756.98M
2025 (actual)
Net Income
₩16,594.17M
2025 (actual)
Valuation
₩787,318.47M
2026 (forecast)
Stock Price
₩120,800
Historical & projected performance
KRW|Millions
Reported figures and Equlion model projections for the next 5 years.
ROE
-18.5 pt
Company
ROA
-8.1 pt
Company
Gross Margin
-8 pt
Company
Sector average
Net Margin
-17 pt
Company
Total Assets
+51.7%
Company
Sector average
Net Income
-374.9%
Company
Sector average (own scale)
Valuation
+175.1%
Company
Sector average
Stock Price
+175.1%
Company
Sector average
Amounts in KRW (millions); stock price per share. Values that are missing or fail Equlion's automated data-quality checks are shown as “-”. Stock price and valuation carry no data date: they are the Equlion model's estimate for 2026. Projections are model estimates, not investment advice.
Want the full financial forecast report for Medy-Tox Inc.? It covers the balance sheet, income statement, cash flow and Equlion model projections.